NorthCrest Asset Manangement’s Bristol-Myers Squibb BMY Stock Holding History

NorthCrest Asset Manangement’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.4M	Buy	300,416 +3,934	+1%	+$226K	0.45%	50
2026 Q1	$17.7M	Sell	296,482 -166,351	-36%	-$9.7M	0.55%	44
2025 Q4	$24.6M	Buy	462,833 +36,677	+9%	+$1.76M	0.55%	42
2025 Q3	$19M	Buy	426,156 +362,156	+566%	+$16.9M	0.45%	65
2025 Q2	$3M	Sell	64,000 -3,070	-5%	-$151K	0.08%	177
2025 Q1	$4.09M	Sell	67,070 -47,889	-42%	-$2.79M	0.12%	150
2024 Q4	$6.5M	Sell	114,959 -39,374	-26%	-$2.2M	0.19%	119
2024 Q3	$7.99M	Sell	154,333 -3,089	-2%	-$145K	0.24%	108
2024 Q2	$6.54M	Sell	157,422 -3,291	-2%	-$147K	0.22%	119
2024 Q1	$8.72M	Buy	160,713 +10,744	+7%	+$547K	0.3%	99
2023 Q4	$7.69M	Sell	149,969 -12,082	-7%	-$634K	0.29%	105
2023 Q3	$9.41M	Buy	162,051 +2,090	+1%	+$128K	0.38%	85
2023 Q2	$10.2M	Buy	159,961 +1,787	+1%	+$120K	0.4%	81
2023 Q1	$11M	Buy	158,174 +35,074	+28%	+$2.47M	0.46%	74
2022 Q4	$8.86M	Sell	123,100 -24	-0%	-$1.81K	0.5%	69
2022 Q3	$8.75M	Buy	123,124 +1,620	+1%	+$118K	0.47%	78
2022 Q2	$9.36M	Buy	121,504 +2,052	+2%	+$156K	0.48%	76
2022 Q1	$8.72M	Buy	119,452 +12,944	+12%	+$869K	0.41%	88
2021 Q4	$6.64M	Buy	+106,508	New	+$6.25M	0.36%	90

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NorthCrest Asset Manangement's BMY Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its Bristol-Myers Squibb (BMY) stake by 1.3% in Q2 2026, buying an estimated $226K and bringing the position to 300,416 shares worth $17.4M. The position accounts for 0.45% of the portfolio, ranked #50.

NorthCrest Asset Manangement first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $24.6M in Q4 2025. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

NorthCrest Asset Manangement held 300,416 shares of Bristol-Myers Squibb worth $17.4M as of Q2 2026.
NorthCrest Asset Manangement bought 3,934 Bristol-Myers Squibb shares in Q2 2026, an estimated $226K.
Bristol-Myers Squibb made up 0.45% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #50 holding.
NorthCrest Asset Manangement first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
NorthCrest Asset Manangement's Bristol-Myers Squibb position peaked at $24.6M in Q4 2025.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.